Please login to the form below

US and Canada

This page shows the latest US and Canada news and features for those working in and with pharma, biotech and healthcare.

‘Missing protein’ biotech Stoke raises $142m in IPO

Continues pioneering research. Stoke Therapeutics has listed on the Nasdaq in the US, raising $142m to advance its pipeline of drugs that aim to restore missing protein expression in genetic diseases. ... treat the disorder, which affects roughly 35, 000

Latest news

Roche/GE’s digital medicine alliance bears first fruit

Roche. For now, the dashboard is only available in the US and Canada. ... Thrive has just raised $110m in a Series A financing that will help it develop CancerSEEK, a liquid biopsy test developed at Johns Hopkins University in the US and currently being
Sobi shows strong growth despite haemophilia competition

countries. Marketing rights to the drugs in the US, Canada and Japan are held by Bioverativ, which was acquired last year by Sanofi. ... The ultra-rare disease therapy was licensed from Novimmune for $452m last year, and gives Sobi an expanded presence
The Final Frontier

But let’s talk about gabapentin. In Canada and the US, gabapentin is indicated as an adjunctive therapy for patients with epilepsy, who are not adequately controlled with conventional therapy. ... But what I do know is that the legalisation of medical
Symkevi approval in Europe helps Vertex expand CF treatment

The new combination has shown greater efficacy than Orkambi and with fewer side effects. ... The new combination was approved by the FDA and is known as Symdeko in the US and Canada.
AZ rival to GSK’s COPD drug Anoro fails head-to-head test

At stake is a share of a big and expanding market for COPD therapies, estimated at well over $15bn in the US and top five EU markets alone in 2016 but ... Bevespi is a newer entrant, picking up its first OK in the US in 2016 and also approved in Canada,

More from news
Approximately 0 fully matching, plus 244 partially matching documents found.

Latest Intelligence

Deal Watch October 2018

US. US and Canada only. # US and EU. Roche’s collaboration with Ionis Pharmaceuticals has a headline of $760m, $1m more than the Tusk deal. ... milestones and royalties, and US profits or losses will be split 50:50.
Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

She is Alnylam’s senior vice president, Europe and Canada and is based at the firm’s European headquarters in Zug, Switzerland. ... In the US and Canada, the company has launched Alynlam Act, a free of charge genetic testing and counselling service.
Deal Watch February 2017

In addition to the upfront and milestone payments, Immunomedics will receive tiered double digit royalties on global net sales, retains an option to co-promote IMMU-132 in the US and ... First approved in North America in 1989, Zoladex sales in 2016 were
2016: The year when deal-makers took stock?

Compounding this was the current political uncertainty following regime change in the US and Brexit, with the latter appearing to encourage caution in deal-making which may well continue into 2017. ... This has provided an opportunity for companies
Deal Watch October 2016

$4, 300 royalty. Buyout of collaboration. Respiratory 2015. Actavis US and Canada. ... The biosimilar market is heating up. This month Teva has entered into a US and Canada commercialisation arrangement with South Korea's Celltrion.

More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.

Latest appointments

NDA bolsters its senior team

US, Europe, Canada and other markets. ... Her contributions will help propel client strategy and accelerate programmes across the EU and US, as well as result in new intriguing service offerings that enable innovative companies to navigate the
Celgene’s president and COO to retire

Smith has over 30 years of business strategy experience across a range of therapeutic areas, having previously held senior leadership roles at Biovail in Canada, France, the US and Hong Kong, ... Smith's successor, Curran, joined Celgene in 2013 as the
Bayer appoints president of Americas pharma business

Dr Carsten Brunn to lead operations across the US, Canada, Central and Latin America. ... Bayer has appointed Dr Carsten Brunn as the president of its pharmaceuticals business in the Americas, overseeing the company's operations in the US, Canada and
Vikas Sinha joins Verona as non-executive director

Brings strong US and financial experience to the UK drug development firm. ... Prior to that he spent 11 years at Bayer, holding roles in the US, Canada, Japan and Germany, latterly as chief financial officer for Bayer Pharmaceuticals Corporation in the
Merck appoints new North America and China biopharma leaders

He will be responsible for the Massachusetts-based biopharma business' strategic direction and growth across the US and Canada. . ... chief commercial officer for the US.

More from appointments
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest from PMHub

Acute leukaemia patients get new online information centre that will help them get the best possible care

access to new treatments and clinical trials often depends on where they live. ... Most importantly, the panel of experts from the UK, Italy, France, Spain, Germany, Canada and the US provides insights into how to get the best from a healthcare team,
Acute leukaemia patients get new online information centre that will help them get the best possible care

Most importantly, the panel of experts from the UK, Italy, France, Spain, Germany, Canada and the US provides insights into how to get the best from a healthcare team, including what ... Visit us on: www.patientpower.eu . Follow us on
GCI Health launches global medical education offer with new appointment

She has previously held leadership roles at HealthEd, Delta Kn and TVF Communications. . ... US, Canada and Europe, our client roster spans broadly across many sectors in healthcare, including pharmaceutical, biotech, medical technology, consumer health
GCI Health makes senior promotions and expands team with an additional two hires

Specialist healthcare communications agency GCI Health makes two senior promotions and the agency continues to expand following two new hires. ... relations. With more than 140 professionals across the US, Canada and Europe, our client roster spans
GCI Health expands London team with five new hires

I am thrilled to be a part of GCI Health; the team has experienced such incredible recent success and I look forward to contributing to the next phase of the ... relations. With more than 140 professionals across the US, Canada and Europe, our client